Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.
Standard
Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype. / Fonseca, Tatiana L; Jorgetti, Vanda; Costa, Cristiane C; Capelo, Luciane P; Covarrubias, Ambart E; Moulatlet, Ana C; Teixeira, Marilia B; Hesse, Eric; Morethson, Priscilla; Beber, Eduardo H; Freitas, Fatima R; Wang, Charles C; Nonaka, Keico O; Oliveira, Ricardo; Casarini, Dulce E; Zorn, Telma M; Brum, Patricia C; Gouveia, Cecilia H.
In: J BONE MINER RES, Vol. 26, No. 3, 3, 2011, p. 591-603.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.
AU - Fonseca, Tatiana L
AU - Jorgetti, Vanda
AU - Costa, Cristiane C
AU - Capelo, Luciane P
AU - Covarrubias, Ambart E
AU - Moulatlet, Ana C
AU - Teixeira, Marilia B
AU - Hesse, Eric
AU - Morethson, Priscilla
AU - Beber, Eduardo H
AU - Freitas, Fatima R
AU - Wang, Charles C
AU - Nonaka, Keico O
AU - Oliveira, Ricardo
AU - Casarini, Dulce E
AU - Zorn, Telma M
AU - Brum, Patricia C
AU - Gouveia, Cecilia H
PY - 2011
Y1 - 2011
N2 - Evidence demonstrates that sympathetic nervous system (SNS) activation causes osteopenia via ?(2)-adrenoceptor (?2-AR) signaling. Here we show that female mice with chronic sympathetic hyperactivity owing to double knockout of adrenoceptors that negatively regulate norepinephrine release, ?(2A)-AR and ?(2C)-AR (?(2A) /?(2C)-ARKO), present an unexpected and generalized phenotype of high bone mass with decreased bone resorption and increased formation. In ?(2A) /?(2C)-ARKO versus wild-type (WT) mice, micro-computed tomographic (µCT) analysis showed increased, better connected, and more plate-shaped trabeculae in the femur and vertebra and increased cortical thickness in the vertebra, whereas biomechanical analysis showed increased tibial and femoral strength. Tibial mRNA expression of tartrate-resistant acid phosphatase (TRACP) and receptor activator of NF-?B (RANK), which are osteoclast-related factors, was lower in knockout (KO) mice. Plasma leptin and brain mRNA levels of cocaine amphetamine-regulated transcript (CART), which are factors that centrally affect bone turnover, and serum levels of estradiol were similar between mice strains. Tibial ?(2)-AR mRNA expression also was similar in KO and WT littermates, whereas ?(2A)-, ?(2B)- and ?(2C)-AR mRNAs were detected in the tibia of WT mice and in osteoblast-like MC3T3-E1 cells. By immunohistochemistry, we detected ?(2A)-, ?(2B)-, ?(2C)- and ?(2)-ARs in osteoblasts, osteoclasts, and chondrocytes of 18.5-day-old mouse fetuses and 35-day-old mice. Finally, we showed that isolated osteoclasts in culture are responsive to the selective ?(2)-AR agonist clonidine and to the nonspecific ?-AR antagonist phentolamine. These findings suggest that ?(2)-AR is not the single adrenoceptor involved in bone turnover regulation and show that ?(2)-AR signaling also may mediate the SNS actions in the skeleton.
AB - Evidence demonstrates that sympathetic nervous system (SNS) activation causes osteopenia via ?(2)-adrenoceptor (?2-AR) signaling. Here we show that female mice with chronic sympathetic hyperactivity owing to double knockout of adrenoceptors that negatively regulate norepinephrine release, ?(2A)-AR and ?(2C)-AR (?(2A) /?(2C)-ARKO), present an unexpected and generalized phenotype of high bone mass with decreased bone resorption and increased formation. In ?(2A) /?(2C)-ARKO versus wild-type (WT) mice, micro-computed tomographic (µCT) analysis showed increased, better connected, and more plate-shaped trabeculae in the femur and vertebra and increased cortical thickness in the vertebra, whereas biomechanical analysis showed increased tibial and femoral strength. Tibial mRNA expression of tartrate-resistant acid phosphatase (TRACP) and receptor activator of NF-?B (RANK), which are osteoclast-related factors, was lower in knockout (KO) mice. Plasma leptin and brain mRNA levels of cocaine amphetamine-regulated transcript (CART), which are factors that centrally affect bone turnover, and serum levels of estradiol were similar between mice strains. Tibial ?(2)-AR mRNA expression also was similar in KO and WT littermates, whereas ?(2A)-, ?(2B)- and ?(2C)-AR mRNAs were detected in the tibia of WT mice and in osteoblast-like MC3T3-E1 cells. By immunohistochemistry, we detected ?(2A)-, ?(2B)-, ?(2C)- and ?(2)-ARs in osteoblasts, osteoclasts, and chondrocytes of 18.5-day-old mouse fetuses and 35-day-old mice. Finally, we showed that isolated osteoclasts in culture are responsive to the selective ?(2)-AR agonist clonidine and to the nonspecific ?-AR antagonist phentolamine. These findings suggest that ?(2)-AR is not the single adrenoceptor involved in bone turnover regulation and show that ?(2)-AR signaling also may mediate the SNS actions in the skeleton.
KW - Animals
KW - Female
KW - Mice
KW - Mice, Knockout
KW - Phenotype
KW - Osteogenesis/drug effects
KW - Adrenergic alpha-2 Receptor Agonists/pharmacology
KW - Bone Resorption/blood/complications/genetics
KW - Bone and Bones/drug effects/metabolism/pathology
KW - Brain/drug effects/metabolism
KW - Estradiol/blood
KW - Gene Deletion
KW - Gene Expression Regulation/drug effects
KW - Hyperkinesis/blood/complications/pathology
KW - Leptin/blood
KW - Myocardium/metabolism
KW - Nerve Tissue Proteins/metabolism
KW - Norepinephrine/blood
KW - Organ Size/drug effects
KW - Osteoclasts/drug effects/pathology
KW - Receptors, Adrenergic, alpha-2/metabolism
KW - Sympathetic Nervous System/drug effects/pathology
KW - Animals
KW - Female
KW - Mice
KW - Mice, Knockout
KW - Phenotype
KW - Osteogenesis/drug effects
KW - Adrenergic alpha-2 Receptor Agonists/pharmacology
KW - Bone Resorption/blood/complications/genetics
KW - Bone and Bones/drug effects/metabolism/pathology
KW - Brain/drug effects/metabolism
KW - Estradiol/blood
KW - Gene Deletion
KW - Gene Expression Regulation/drug effects
KW - Hyperkinesis/blood/complications/pathology
KW - Leptin/blood
KW - Myocardium/metabolism
KW - Nerve Tissue Proteins/metabolism
KW - Norepinephrine/blood
KW - Organ Size/drug effects
KW - Osteoclasts/drug effects/pathology
KW - Receptors, Adrenergic, alpha-2/metabolism
KW - Sympathetic Nervous System/drug effects/pathology
M3 - SCORING: Journal article
VL - 26
SP - 591
EP - 603
JO - J BONE MINER RES
JF - J BONE MINER RES
SN - 0884-0431
IS - 3
M1 - 3
ER -